The treatment of nonseminomatous testicular tumors: 15 years experience

M. Steiner, M. Stein, Y. Cohen, E. Robinson

Research output: Contribution to journalArticlepeer-review


Thirty‐two patients with nonseminomatous germ cell tumors of the testis were treated at the Northern Israel. Oncology Center during the years 1968‐1983. The patients were divided into two groups. Group I included 18 patients treated from 1968 to 1976; in group II there were 14 patients treated with combination therapy containing cis‐platinum in the years 1977 to 1983. The actuarial survival rate at 38 months from diagnosis is 47% in group I patients and 86% in group II patients. The development of modern radiological techniques, biochemical markers for accurate staging, and the use of cis‐platinum‐containing combination chemotherapy made this disease curable. New treatment modalities are needed for patients with bulky disease at presentation.

Original languageEnglish
Pages (from-to)141-144
Number of pages4
JournalJournal of Surgical Oncology
Issue number3
StatePublished - 1 Jan 1986
Externally publishedYes


  • increased survival
  • nonseminomatous tumor
  • platinol‐based chemotherapy

ASJC Scopus subject areas

  • Surgery
  • Oncology


Dive into the research topics of 'The treatment of nonseminomatous testicular tumors: 15 years experience'. Together they form a unique fingerprint.

Cite this